New inhaled therapy for tough fungus infections falls short in trial
Disease control
Terminated
This study tested whether adding an inhaled antifungal drug (PC945) to standard treatment could help people with a serious lung fungus infection that wasn't getting better. The trial was stopped early, so we don't have clear proof it works. About 85 adults with proven or probable…
Phase: PHASE3 • Sponsor: Pulmocide Ltd • Aim: Disease control
Last updated May 17, 2026 16:06 UTC